Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1989-07-27
1991-06-18
Dentz, Bernard I.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514315, 514328, 546116, 546219, 546220, 546242, A61K 31445, C07D21146, C07D491056
Patent
active
050250213
ABSTRACT:
Novel compounds represented by the formula: ##STR1## wherein R represents hydrogen, optionally substituted alkyl radicals having from 1 to about 10 carbon atoms, optionally substituted alkenyl radicals having from 1 to about 10 carbon atoms, optionally substituted aryl, alkaryl and aralkyl radicals having from about 6 to about 16 carbon atoms and optionally substituted acyl and acyloxy radicals having from about 1 to about 10 carbon atoms, manifest glycosidase inhibition activity.
REFERENCES:
patent: 4348402 (1982-09-01), Kinast et al.
Minavu et al, J. Org. Chem., 41 1831 (1976).
David et al, Tetrahedron, 41, (4), 643 (1985).
Tsuda et al, Chem. Pharm. Bull., 31(5), 1612 (1983).
Boshagan et al, Carbohydrate Research, 164, 141 (1987).
DeCrescenzo Gary A.
Getman Daniel P.
Bolding James C.
Dentz Bernard I.
Monsanto Company
Smith Charles E.
Williams, Jr. James W.
LandOfFree
1,2-dideoxy-2-fluoronojirimycin as glycosidase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1,2-dideoxy-2-fluoronojirimycin as glycosidase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1,2-dideoxy-2-fluoronojirimycin as glycosidase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-146053